PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company.
Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies.
“The unveiling of Revvity is the capstone of a nearly year-long journey that has transformed who we are and reinforces why our work matters,” said Prahlad Singh, President and Chief Executive Officer of Revvity.
“With cross-business collaborations between our automation, multi-omics offerings, and our Signals software business, we have unique capabilities which put us in an optimal position to accelerate breakthrough solutions – starting with preclinical research and scientific discovery, all the way through to diagnosing and helping to treat disease.”
The company’s software platform, previously known as PerkinElmer Informatics, will become Revvity Signals Software, while Revvity Omics will replace PerkinElmer Genomics.
Cisbio, Horizon Discovery, Nexcelom Bioscience, Omni International, Oxford Immunotec, SIRION Biotech and SonoVol will come under the Revvity banner, while maintaining their specific product names.
Franchises, BioLegend, EUROIMMUN, Tulip Diagnostics and ViaCord will retain their own names as unique product lines.